22 parallel-computing-"Institute-for-Advanced-Studies" Coursework positions at Newcastle University
Sort by
Refine Your Search
-
candidates who can demonstrate substantial experience of leading sustainable and or social business initiatives. The successful candidate will also be an inspirational role model for peers and
-
application deadline will be extended. Sponsor Newcastle University Business School Eligibility Criteria To be eligible for this full-fee scholarship you must meet the following criteria. You must hold
-
eligible for this partial-fee scholarship you must meet the following criteria. You must: be able to demonstrate (through application and at interview) substantive managerial experience and good
-
University Business School Eligibility Criteria To be eligible for this partial-fee scholarship you must meet the following criteria. You must: be able to demonstrate (through application and at interview
-
Eligibility Criteria To be eligible for this full-fee scholarship you must meet the following criteria. You must: identify as female hold an offer (conditional or unconditional) for admission in
-
Eligibility Criteria To be eligible for this partial-fee scholarship you must meet the following criteria. You must: be able to demonstrate (through application and at interview) substantive managerial
-
and reward high calibre applicants who apply to commence full-time postgraduate taught studies. Our Entrepreneurship and Innovation Management scholarship is intended to foster an interest and build
-
Eligibility Criteria A minimum 2:1 Honours degree or international equivalent in a subject relevant to the proposed PhD project ( inc. geospatial engineering, computing, and mathematics). Enthusiasm for
-
vulnerable to life-threatening infections. While some genes linked to CID have specific roles in the immune system, others are involved in essential cellular processes that occur in all cells. For example
-
, purified and tested for biological activity together, in a single operation taking as little as a week. You will apply this new approach to real drug targets in cancer, working at the interface of